International audienceBackground. The primary aim of this study was to determine the impact of regulatory T cells (Tregs) percentage on immune recovery in human immunodeficiency virus (HIV)-infected patients after antiretroviral therapy introduction. Methods. A 2-year prospective study was conducted in HIV-1 chronically infected naive patients with CD4 count \textless500 cells/mm(3). Regulatory T cells were identified as CD4(+)CD25(high)CD127(low) cells among CD4(+) lymphocytes. Effect of Treg percentage at inclusion on CD4 evolution overtime was analyzed using a mixed-effect Poisson regression for count data. Results. Fifty-eight patients were included (median CD4 = 293/mm(3), median Treg percentage = 6.1%). Percentage of Treg at baseline ...
BACKGROUND: Persistently reduced CD4(+) T-lymphocyte counts in the face of undetectable HIV viremia ...
Background: A major question when attempting to eradicate and treat HIV-1 infection is how to reacti...
OBJECTIVE:Treatment guidelines recommend initiation of therapy for individuals experiencing rapid CD...
International audienceBackground. The primary aim of this study was to determine the impact of regul...
<div><p>CD4<sup>+</sup> regulatory T cells (Tregs) are essential for the maintenance of the immune s...
CD4(+) regulatory T cells (Tregs) are essential for the maintenance of the immune system's equilibri...
Objective: To examine the relationships between blood CD4 natural regulatory T (T-reg) cells, plasma...
Objectives: A sizeable percentage of individuals infected by HIV and on antiretroviral therapy (ART...
International audienceOBJECTIVE: Expansion of regulatory T (Treg) cells has been described in chroni...
Background. The reason why HIV-infected patients receiving highly active antiretroviral therapy (HAA...
There are conflicting data about the frequency and role of regulatory T cells (Tregs) during the cou...
BACKGROUND: The CD4 T cell count recovery in human immunodeficiency virus type 1 (HIV-1)-infected in...
BackgroundWhile persistent T-cell activation has been cross-sectionally associated with poor CD4+ T-...
International audienceThe mechanisms sustaining the absence of complete immune recovery in HIV-infec...
© 2011 Wolters Kluwer Health | Lippincott Williams & WilkinsObjective: The dynamics of CD4+ regulato...
BACKGROUND: Persistently reduced CD4(+) T-lymphocyte counts in the face of undetectable HIV viremia ...
Background: A major question when attempting to eradicate and treat HIV-1 infection is how to reacti...
OBJECTIVE:Treatment guidelines recommend initiation of therapy for individuals experiencing rapid CD...
International audienceBackground. The primary aim of this study was to determine the impact of regul...
<div><p>CD4<sup>+</sup> regulatory T cells (Tregs) are essential for the maintenance of the immune s...
CD4(+) regulatory T cells (Tregs) are essential for the maintenance of the immune system's equilibri...
Objective: To examine the relationships between blood CD4 natural regulatory T (T-reg) cells, plasma...
Objectives: A sizeable percentage of individuals infected by HIV and on antiretroviral therapy (ART...
International audienceOBJECTIVE: Expansion of regulatory T (Treg) cells has been described in chroni...
Background. The reason why HIV-infected patients receiving highly active antiretroviral therapy (HAA...
There are conflicting data about the frequency and role of regulatory T cells (Tregs) during the cou...
BACKGROUND: The CD4 T cell count recovery in human immunodeficiency virus type 1 (HIV-1)-infected in...
BackgroundWhile persistent T-cell activation has been cross-sectionally associated with poor CD4+ T-...
International audienceThe mechanisms sustaining the absence of complete immune recovery in HIV-infec...
© 2011 Wolters Kluwer Health | Lippincott Williams & WilkinsObjective: The dynamics of CD4+ regulato...
BACKGROUND: Persistently reduced CD4(+) T-lymphocyte counts in the face of undetectable HIV viremia ...
Background: A major question when attempting to eradicate and treat HIV-1 infection is how to reacti...
OBJECTIVE:Treatment guidelines recommend initiation of therapy for individuals experiencing rapid CD...